SOC status:Duty analyst on shift

UK Cyber Defence
VulnerabilityModified

CVE-2018-14786

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform…

CRITICAL 9.4EPSS 3.06%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (3.06%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

CVSS 3.0
9.4 CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
EPSS
3.06% probability · 88th percentile
Public exploits
None in Exploit-DB
CISA KEV
Not listed
Weakness
CWE-287
Affected
bd/alaris gs firmware · bd/alaris gh firmware · bd/alaris cc firmware · bd/alaris tiva firmware
Source
ics-cert@hq.dhs.gov
EPSS trend
0%3%5%27 October 2026: 3.06%27 October 202627 October 2026

EPSS 3.1% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.

Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.